Pathogenic microbes, the microbiome, and Alzheimer's disease (AD)

Affiliations

¹ Department of Microbiology, Immunology & Parasitology, Louisiana State University Health Sciences Center New Orleans, USA ; LSU Neuroscience Center, Louisiana State University Health Sciences Center New Orleans, USA ; Department of Ophthalmology, Louisiana State University Health Sciences Center New Orleans, USA.
² Department of Ophthalmology, Louisiana State University Health Sciences Center New Orleans, USA.
³ Alchem Biotek Toronto, ON, Canada.
⁴ LSU Neuroscience Center, Louisiana State University Health Sciences Center New Orleans, USA.
⁵ LSU Neuroscience Center, Louisiana State University Health Sciences Center New Orleans, USA ; Department of Ophthalmology, Louisiana State University Health Sciences Center New Orleans, USA ; Alchem Biotek Toronto, ON, Canada ; Department of Neurology, Louisiana State University Health Sciences Center New Orleans, USA.

James M Hill et al. Front Aging Neurosci. 2014.

. 2014 Jun 16:6:127.

doi: 10.3389/fnagi.2014.00127. eCollection 2014.

¹ Department of Microbiology, Immunology & Parasitology, Louisiana State University Health Sciences Center New Orleans, USA ; LSU Neuroscience Center, Louisiana State University Health Sciences Center New Orleans, USA ; Department of Ophthalmology, Louisiana State University Health Sciences Center New Orleans, USA.
² Department of Ophthalmology, Louisiana State University Health Sciences Center New Orleans, USA.
³ Alchem Biotek Toronto, ON, Canada.
⁴ LSU Neuroscience Center, Louisiana State University Health Sciences Center New Orleans, USA.
⁵ LSU Neuroscience Center, Louisiana State University Health Sciences Center New Orleans, USA ; Department of Ophthalmology, Louisiana State University Health Sciences Center New Orleans, USA ; Alchem Biotek Toronto, ON, Canada ; Department of Neurology, Louisiana State University Health Sciences Center New Orleans, USA.

No abstract available

Keywords: Alzheimer’s disease; miRNA; microbiome; prion; virus replication.

References

1. Agostini S., Clerici M., Mancuso R. (2014). How plausible is a link between HSV-1 and AD? Expert Rev. Anti. Infect. Ther. 12, 275–278 10.1586/14787210.2014.887442 - DOI - PubMed
1. Alexandrov P. N., Dua P., Hill J. M., Bhattacharjee S., Zhao Y., Lukiw W. J. (2012). microRNA (miRNA) speciation in Alzheimer’s disease (AD) cerebrospinal fluid (CSF) and extracellular fluid (ECF). Int. J. Biochem. Mol. Biol. 3, 365–373 - PMC - PubMed
1. Alonso R., Pisa D., Marina A. I., Morato E., Rábano A., Carrasco L. (2014). Fungal infection in patients with Alzheimer’s disease. J. Alzheimers Dis. 41, 301–311 10.3233/JAD-132681 - DOI - PubMed
1. Asti A., Gioglio L. (2014). Can a bacterial endotoxin be a key factor in the kinetics of amyloid fibril formation? J. Alzheimers. Dis. 39, 169–179 10.3233/JAD-131394 - DOI - PubMed
1. Balin B. J., Hudson A. P. (2014). Etiology and pathogenesis of AD. Curr. Allergy Asthma Rep. 14, 417 10.1007/s11882-013-0417-1 - DOI - PubMed